Altered toll-like receptor signaling pathways in human type 1 diabetes

Journal of Molecular Medicine

Volumn 88, Issue 12, 2010, Pages 1221-1231

  Meyers, Adam J ^a   Shah, Roopali R ^a   Gottlieb, Peter A ^a   Zipris, Danny ^a  

^a UNIVERSITY OF COLORADO DENVER   (United States)

Author keywords

Cytokines; Dendritic cells; Innate immunity; Monocytes; Toll like receptor; Type 1 diabetes

Indexed keywords

ALPHA INTERFERON; ALPHA2 INTERFERON; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HEMOGLOBIN A1C; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; RESIQUIMOD; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7;

ADOLESCENT; ADULT; ARTICLE; BONE MARROW CELL; CHILD; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; GENETIC SUSCEPTIBILITY; HUMAN; INCUBATION TIME; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MONOCYTE; MYELOID DENDRITIC CELL; OBSERVATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMACYTOID DENDRITIC CELL; PRESCHOOL CHILD; PROTEIN FUNCTION; SCHOOL CHILD; SERUM;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CHEMOKINES; CHILD; CHILD, PRESCHOOL; DENDRITIC CELLS; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; INFLAMMATION MEDIATORS; MALE; MONOCYTES; NF-KAPPA B; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS; UP-REGULATION; YOUNG ADULT;

EID: 78651345190     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-010-0666-6     Document Type: Article

References (35)

1. Medzhitov R (2007) Recognition of microorganisms and activation of the immune response. Nature 449:819-826
2. Lien E, Zipris D (2009) The role of toll-like receptor pathways in the mechanism of type 1 diabetes. Curr Mol Med 9:52-68
3. Zipris D (2008) Innate immunity and its role in type 1 diabetes. Curr Opin Endocrinol Diabetes Obes 15:326-331
4. Theofilopoulos AN, Baccala R, Beutler B, Kono DH (2005) Type I interferons (alpha/beta) in immunity and autoimmunity. Annu Rev Immunol 23:307-336
5. Achenbach P, Bonifacio E, Koczwara K, Ziegler AG (2005) Natural history of type 1 diabetes. Diabetes 54 (Suppl 2): S25-S31
6. Jimi E, Ghosh S (2005) Role of nuclear factor-kappaB in the immune system and bone. Immunol Rev 208:80-87
7. Bradshaw EM, Raddassi K, Elyaman W, Orban T, Gottlieb PA, Kent SC, Hafler DA (2009) Monocytes from patients with type 1 diabetes spontaneously secrete proinflammatory cytokines inducing Th17 cells. J Immunol 183:4432-4439
8. Devaraj S, Dasu MR, Rockwood J, Winter W, Griffen SC, Jialal I (2008) Increased Toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with Type 1 diabetes: further evidence of a proinflammatory state. J Clin Endocrinol Metab 93:578-583
9. Devaraj S, Jialal I (2009) Increased secretion of IP-10 from monocytes under hyperglycemia is via the TLR2 and TLR4 pathway. Cytokine 47:6-10
10. Christensen SR, Shupe J, Nickerson K, Kashgarian M, Flavell R, Shlomchik MJ (2006) Toll-like Receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity 25:417-428
11. Hober D, Chehadeh W, Weill J, Hober C, Vantyghem MC, Gronnier P, Wattre P (2002) Circulating and cell-bound antibodies increase coxsackievirus B4-induced production of IFN-{alpha} by peripheral blood mononuclear cells from patients with type 1 diabetes. J Gen Virol 83:2169-2176
12. Triantafilou K, Orthopoulos G, Vakakis E, Ahmed MAE, Golenbock DT, Lepper PM, Triantafilou M (2005) Human cardiac inflammatory responses triggered by Coxsackie B viruses are mainly Toll-like receptor (TLR) 8-dependent. Cell Microbiol 7:1117-1126
13. Ueno H, Klechevsky E, Morita R, Aspord C, Cao T, Matsui T, Di Pucchio T, Connolly J, Fay JW, Pascual V, Palucka AK, Banchereau J (2007) Dendritic cell subsets in health and disease. Immunol Rev 219:118-142
14. Uno S, Imagawa A, Okita K, Sayama K, Moriwaki M, Iwahashi H, Yamagata K, Tamura S, Matsuzawa Y, Hanafusa T, Miyagawa J, Shimomura I (2007) Macrophages and dendritic cells infiltrating islets with or without beta cells produce tumour necrosis factor-alpha in patients with recent-onset type 1 diabetes. Diabetologia 50:596-601
15. Chehadeh W, Weill J, Vantyghem M-C, Alm G, Lefebvre J, Wattre P, Hober D (2000) Increased level of interferon-α in blood of patients with insulin-dependent diabetes mellitus: relationship with coxsackievirus B infection. J Infect Dis 181:1929-1939
16. Baccala R, Kono DH, Theofilopoulos AN (2005) Interferons as pathogenic effectors in autoimmunity. Immunol Rev 204:9-26
17. Montoya M, Schiavoni G, Mattei F, Gresser I, Belardelli F, Borrow P, Tough DF (2002) Type I interferons produced by dendritic cells promote their phenotypic and functional activation. Blood 99:3263-3271
18. Nikolic T, Welzen-Coppens JMC, Leenen PJM, Drexhage HA, Versnel MA (2009) Plasmacytoid dendritic cells in autoimmune diabetes - Potential tools for immunotherapy. Immunobiology 214:791-799
19. Summers KL, Behme MT, Mahon JL, Singh B (2003) Characterization of dendritic cells in humans with type 1 diabetes. Ann NY Acad Sci 1005:226-229
20. Peng R, LI Y, Brezner K, Litherland S, Clare-Salzler MJ (2003) Abnormal peripheral blood dendritic cell populations in type 1 diabetes. Ann NY Acad Sci 1005:222-225
21. Allen JS, Pang K, Skowera A, Ellis R, Rackham C, Lozanoska-Ochser B, Tree T, Leslie RD, Tremble JM, Dayan CM, Peakman M (2009) Plasmacytoid dendritic cells are proportionally expanded at diagnosis of type 1 diabetes and enhance islet autoantigen presentation to T-cells through immune complex capture. Diabetes 58:138-145
22. Summers KL, Marleau AM, Mahon JL, McManus R, Hramiak I, Singh B (2006) Reduced IFN-[alpha] secretion by blood dendritic cells in human diabetes. Clin Immunol 121:81-89
23. Chen X, Makala LHC, Jin Y, Hopkins D, Muir A, Garge N, Podolsky RH, She JX (2008) Type 1 diabetes patients have significantly lower frequency of plasmacytoid dendritic cells in the peripheral blood. Clin Immunol 129:413-418
24. Kishimoto T (2006) Interleukin-6: discovery of a pleiotropic cytokine. Arthritis Res Ther 8: S2
25. Kimura A, Naka T, Kishimoto T (2007) IL-6-dependent and -independent pathways in the development of interleukin 17-producing T helper cells. Proc Natl Acad Sci USA 104:12099-12104
26. Ishihara K, Hirano T (2002) IL-6 in autoimmune disease and chronic inflammatory proliferative disease. Cytokine Growth Factor Rev 13:357-368
27. Niemand C, Nimmesgern A, Haan S, Fischer P, Schaper F, Rossaint R, Heinrich PC, Muller-Newen G (2003) Activation of STAT3 by IL-6 and IL-10 in Primary Human Macrophages Is Differentially Modulated by Suppressor of Cytokine Signaling 3. J Immunol 170:3263-3272
28. Deon D, Ahmed S, Tai K, Scaletta N, Herrero C, Lee IH, Krause A, Ivashkiv LB (2001) Cross-talk between IL-1 and IL-6 signaling pathways in rheumatoid arthritis synovial fibroblasts. J Immunol 167:5395-5403
29. Ernst M, Inglese M, Waring P, Campbell IK, Bao S, Clay FJ, Alexander WS, Wicks IP, Tarlinton DM, Novak U, Heath JK, Dunn AR (2001) Defective gp130-mediated signal transducer and activator of transcription (STAT) signaling results in degenerative joint disease, gastrointestinal ulceration, and failure of uterine implantation. J Exp Med 194:189-204
30. Dogan Y, Akarsu S, Ustundag B, Yilmaz E, Gurgoze MK (2006) Serum IL-1beta, IL-2, and IL-6 in insulin-dependent diabetic children. Mediat Inflamm 2006:59206
31. Erbagci AB, Tarakτioglu M, Coskun Y, Sivasli E, Sibel Namiduru E (2001) Mediators of inflammation in children with type I diabetes mellitus: cytokines in type I diabetic children. Clin Biochem 34:645-650
32. Wang X, Jia S, Geoffrey R, Alemzadeh R, Ghosh S, Hessner MJ (2008) Identification of a molecular signature in human type 1 diabetes mellitus using serum and functional genomics. J Immunol 180:1929-1937
33. Liu SF, Malik AB (2006) NF-kappa B activation as a pathological mechanism of septic shock and inflammation. Am J Physiol Lung Cell Mol Physiol 290: L622-L645
34. Dasu MR, Devaraj S, Zhao L, Hwang DH, Jialal I (2008) High glucose induces Toll-like receptor expression in human monocytes: mechanism of activation. Diabetes 57:3090-3098
35. Ghanim H, Mohanty P, Deopurkar R, Sia CL, Korzeniewski K, Abuaysheh S, Chaudhuri A, Dandona P (2008) Acute modulation of toll-like receptors by insulin. Diab Care 31:1827-1831